UNSPSC 51144603: Propentofylline

Commodity

Code facts

NIGP codes
1

UNSPSC codes and definitions come from the UN Development Programme (managed by GS1 US), and state and local contract opportunities from the governments' procurement sites.

NIGP codes for 51144603

Definition

This classification denotes a neuroprotective agent with the molecular formula C15H22N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 5RTA398U4H, chemically known as 3,7-dihydro-3-methyl-1-(5-oxohexyl)-7-propyl-1h-purine-2,6-dione but more generally known as propentofylline, which bears US NIH Compound Identifier 4938. European Medicines Agency schedules Propentofylline in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10102MIG.

Read the full definition

The term PROPENTOFYLLINE is an International Non-Proprietary Name. World Health Organization schedules propentofylline in its Anatomical Therapeutic Chemical (ATC) Classification. PROPENTOFYLLINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule propentofylline under HS 29395900 and SITC 54145. As of Q4 2014, PROPENTOFYLLINE remains US FDA's Preferred Term for this commodity. Propentofylline bears US NLM identifiers UMLS ID C0072171 and NCI Concept Code C81919.

SMILES: O=C1N(CCCCC(=O)C)C(=O)N(C2NCN(C12)CCC)C.

About UNSPSC 51144603

UNSPSC 51144603 Propentofylline is a Commodity code that does not reflect the actual work being solicited under it in recent state and local procurement activity. The sole recent opportunity appearing under this code—Seminole County, Florida's IFB60459723LAS for Naloxone and Safe Drug Deactivation Systems—involves pharmaceuticals and harm-reduction equipment for community health deployment, not propentofylline, a niche pharmaceutical agent used to treat circulatory conditions. The mismatch between the code's nominal scope and the sourced opportunity signals either a cataloging error or a standing code assignment that no longer tracks actual procurement patterns for this drug.

Seminole County released the Naloxone and Safe Drug Deactivation Systems IFB on June 30, 2026, with a response deadline of July 26, 2023 (dates in the source appear inconsistent). The county sought 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually through quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida. Vendors were required to submit bids electronically, include all shipping and delivery costs in proposals, and comply with drug-free workplace certification and E-Verify requirements. The contract carried an initial two-year term with an optional one-year renewal and was potentially funded through FEMA. No explicit set-aside designations were noted. The lack of other recent opportunities under this code, combined with the clear misalignment between the Seminole County solicitation and propentofylline procurement, indicates minimal current state and local activity under the code as currently labeled.

Quick answers

What is UNSPSC 51144603?

UNSPSC 51144603 is Propentofylline, a commodity in UNSPSC 51000000, Pharmaceutical Products incl. Contraceptives and Vaccines.

Which NIGP codes match UNSPSC 51144603?

UNSPSC 51144603 maps to 1 NIGP code, 26928 Central Nervous System Agents (Including: Analegsic, Anticonvulsant, Antidepressant, Antihistamine, Antipsychotic and Sedative).

On GovTribe

See everything under UNSPSC 51144603

  • State & local contract opportunities, awards and contract vehicles under this code
  • Contacts who buy under this code
  • Ask GovTribe AI about this code